Goldman Sachs’s Helus Pharma HELP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$568K Buy
46,222
+26,417
+133% +$276K ﹤0.01% 5625
2026
Q2
$131K Sell
19,805
-31,783
-62% -$159K ﹤0.01% 6297
2026
Q1
$248K Buy
51,588
+3,657
+8% +$23.7K ﹤0.01% 5986
2025
Q4
$392K Buy
+47,931
New +$308K ﹤0.01% 5740
2024
Q1
– Sell
-321
Closed -$5K – 5601
2023
Q4
$5K Buy
+321
New +$5.98K ﹤0.01% 5523

Other funds holding HELP

Goldman Sachs's HELP Position: Q3 2026 in Review

Goldman Sachs increased its Helus Pharma (HELP) stake by 133% in Q3 2026, buying an estimated $276K and bringing the position to 46,222 shares worth $568K. The position accounts for ﹤0.01% of the portfolio, ranked #5625.

Goldman Sachs first reported a position in HELP in Q4 2023 and has held it in 5 quarters since. 110 funds tracked by Wall St. Rank hold HELP as of Q3 2026.

  • Goldman Sachs held 46,222 shares of Helus Pharma worth $568K as of Q3 2026.
  • Goldman Sachs bought 26,417 Helus Pharma shares in Q3 2026, an estimated $276K.
  • Helus Pharma made up ﹤0.01% of Goldman Sachs's portfolio in Q3 2026, its #5625 holding.
  • Goldman Sachs first reported a position in Helus Pharma in Q4 2023 and has held it in 5 quarters since.
  • 110 funds tracked by Wall St. Rank held Helus Pharma as of Q3 2026.

Based on Goldman Sachs's 13F filing for Q3 2026, filed 16 Nov 2026.